CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 658416-658634 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T36757","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T32853","span":{"begin":86,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1435","span":{"begin":0,"end":218},"obj":"Epistemic_statement"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T110","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T111","span":{"begin":86,"end":218},"obj":"Sentence"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1395","span":{"begin":86,"end":105},"obj":"Phenotype"},{"id":"T1396","span":{"begin":107,"end":109},"obj":"Phenotype"}],"attributes":[{"id":"A1395","pred":"hp_id","subj":"T1395","obj":"http://purl.obolibrary.org/obo/HP_0002511"},{"id":"A1396","pred":"hp_id","subj":"T1396","obj":"http://purl.obolibrary.org/obo/HP_0002511"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2740","span":{"begin":82,"end":84},"obj":"Body_part"}],"attributes":[{"id":"A2740","pred":"uberon_id","subj":"T2740","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4108","span":{"begin":82,"end":84},"obj":"Disease"},{"id":"T4109","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"T4110","span":{"begin":107,"end":109},"obj":"Disease"},{"id":"T73068","span":{"begin":82,"end":84},"obj":"Disease"},{"id":"T24287","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"T4088","span":{"begin":107,"end":109},"obj":"Disease"}],"attributes":[{"id":"A4108","pred":"mondo_id","subj":"T4108","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A4109","pred":"mondo_id","subj":"T4109","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A4110","pred":"mondo_id","subj":"T4110","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A71493","pred":"mondo_id","subj":"T73068","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A22759","pred":"mondo_id","subj":"T24287","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A58051","pred":"mondo_id","subj":"T4088","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"Kinetic changes in the IFN pathway might indicate response to IFN-beta therapy in MS. Alzheimer's Disease (AD) is a severe neurodegenerative disorder characterized by progressive loss of memory and cognitive functions."}